Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JB.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JB.1ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
JB.1ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
JB.1ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
JB.1ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
JB.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-3120.32Singapore
JB.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JB.1SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
JB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
JB.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
JB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JB.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JB.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JB.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
JB.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JB.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
JB.1ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
A.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
A.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
A.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
A.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
A.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
A.4ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
A.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
A.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
A.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
A.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
A.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.4NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
A.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
A.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.4NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
A.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
A.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
A.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
A.4ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
XDK.4ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
XDK.4ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
XDK.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDK.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XDK.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XDK.4ORF1abChan-ORF1abCGCATACAGTCTTRCAGGCT20501622016239F-11502.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used